Marksans Pharma announces USFDA approval for Famotidine Tablets
Marksans' OTC Famotidine Tablets USP are acid reducers
Marksans' OTC Famotidine Tablets USP are acid reducers
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
Thiamine Hydrochloride Injection is effective in the treatment of vitamin B1 deficiency (beriberi)
Rocuronium Bromide Injection is a neuromuscular blocking agent
Losartan potassium tablets are indicated for the treatment of hypertension in adults and pediatric patients 6 years of age and older, to lower blood pressure.
The respective product approval is based on Revlimid Capsules, 5mg, 10mg, 15mg, 25mg and 2.5mg, 20mg as a reference product
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
This product is based on Osmotic Controlled Release Oral Delivery System technology
The product is expected to be launched by Q4 FY23.
Subscribe To Our Newsletter & Stay Updated